Clinical Trials Browser

Phase 1/2 × INDUSTRY × Anticoagulants × Clear all

NCT00443573 2008-05-07

Safety Study of Recombinant NAPc2 to Prevent Tumor Progression and Metastases in Metastatic Colon Cancer

Phase 1/2 Suspended

Gastrointestinal

Adenocarcinoma, Colonic Neoplasms, Colorectal Neoplasms